News: St. Jude Medical Inc (STJ)
45.15USD
24 May 2013
$-0.02 (-0.04%)
$45.17
$44.86
$45.44
$44.60
1,085,301
2,435,283
$47.45
$30.25
Mon, May 13 2013
H&M, others back new Bangladesh factory safety accord
STOCKHOLM/MADRID - The world's two biggest fashion retailers, Inditex and H&M, along with several other companies have backed an accord aimed at preventing another disaster like last month's Bangladesh factory building collapse that killed more than 1,100 people.
UPDATE 1-STMicroelectronics posts loss as ST-Ericsson weighs
SAN FRANCISCO, April 22 - European chipmaker STMicroelectronics posted its sixth straight quarterly loss, hurt by costs linked to the closure of joint venture ST-Ericsson and weak European semiconductor demand.
St. Jude Medical profit tops view, forex to hurt revenue
- Medical device maker St. Jude Medical Inc said on Wednesday first-quarter profit rose as lower expenses outweighed a decline in sales but warned that full-year revenue will be hurt by foreign exchange effects.
UPDATE 2-St. Jude Medical profit tops view, forex to hurt revs
April 17 - Medical device maker St. Jude Medical Inc said on Wednesday first-quarter profit rose as lower expenses outweighed a decline in sales but warned that full-year revenue will be hurt by foreign exchange effects.
St. Jude Medical post higher quarterly profit
April 17 - St. Jude Medical Inc said on Wednesday its quarterly earnings rose as expenses fell.
St. Jude wins European OK for brain implant to treat Dystonia
April 10 - St. Jude Medical Inc on Wednesday said it received European regulatory approval for its brain implant used to treat primary and secondary Dystonia, a neurological movement disorder.
Fitch Rates St. Jude Medical's Notes Offering 'A'; Outlook Stable
(The following statement was released by the rating agency) CHICAGO, March 21 (Fitch) Fitch Ratings has assigned an 'A' rating to St. Jude Medical, Inc.'s (STJ) notes offering. The company intends to use the net proceeds of this offering for general corporate purposes, which may include the repayment of certain indebtedness. The Rating Outlook is Stable, and the ratings apply to approximately $3.06 billion of debt outstanding as of Dec. 31, 2012. A full list of STJ's ratings is available a
St Jude Medical's device to prevent stroke misses study goal
- A clinical trial evaluating St. Jude Medical Inc's implantable device used to prevent stroke in patients who have a common congenital heart defect failed to achieve its main goal.
St Jude Medical's device to prevent stroke misses study goal
March 20 - A clinical trial evaluating St. Jude Medical Inc's implantable device used to prevent stroke in patients who have a common congenital heart defect failed to achieve its main goal.
STMicro, Ericsson find no takers for mobile chip unit-report
PARIS, March 12 - STMicroelectronics and Ericsson have failed to find a buyer for their lossmaking wireless electronic chip joint venture and will now consider whether to close the business down, news service Bloomberg said on its website.
- The Next 3-D Printing Revolution: Human Body Parts?
- Johnson & Johnson: At The Crossroads - Part IV - One Road To Higher Profit Growth Rates
- Will Obamacare Crush Medtronic's Earnings?
- Johnson & Johnson: At The Crossroads - Part II
- Lead Situation Improves For St. Jude, But The Future Could Be Wireless
- Billions In Renal Denervation: Medtronic, St Jude
Press Releases
- One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology
- St. Jude Medical EnligHTNment Study Highlighted at EuroPCR During Trials That May Change Clinical Practice Session
- St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care Conference
- St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
- St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013
- St. Jude Medical to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
- St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study
- St. Jude Medical Announces Second Quarter Dividend
- St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
- St. Jude Medical Reports First Quarter 2013 Results

